TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients

Huong D Nguyen, Fabienne Jouen, Benoit Déchelotte, Nadège Cordel, Cyril Gitiaux, Christine Bodemer, Pierre Quartier, Alexandre Belot, Kathryn O’Brien, Dario Cancemi, Isabelle Melki, Nicole Fabien, Sarah Tansley, Olivier Boyer, Lucy R Wedderburn, Brigitte Bader-Meunier

Research output: Contribution to journalArticlepeer-review

1 Citation (SciVal)
Original languageEnglish
Pages (from-to)e281-e284
JournalRheumatology
Volume63
Issue number10
Early online date18 Mar 2024
DOIs
Publication statusPublished - 31 Oct 2024

Data Availability Statement

Data on the cohorts’ studies can be applied to through the corresponding author (LRW).

Funding

Funding for the UK JDM Cohort and Biomarker study has been by grants from the Wellcome Trust UK [085860]; Action Medical Research UK [SP4252]; the Myositis Support Group UK, Arthritis Research UK now Versus Arthritis [14518, 20164, 21593]; the Henry Smith Charity and Great Ormond Street Children's Charity [V1268]; Tiny Hearts Society, Remission Charity, the Myositis Association, Cure JM (GOSH042019), the Medical Research Council [MR/N003322/1], and the National Institute for Health Research (NIHR) via the NIHR-Biomedical Research Centre at GOSH. HDN, LRW, KOB and DC are supported by the NIHR-BRC at GOSH. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. This work was supported by a research grant from Agence Nationale de la Recherche (ANR) via project JDMINF2 (ANR-21-CE17-0025).

Cite this